Article
Detection of common and less frequent EGFR mutations in cytological samples of lung cancer.
Acta cytologica - 1 Jan 2014
Rossi Esther D, Gerhard Renê, Cirnes Luis, Machado José Carlos, Schmitt Fernando
Abstract excerpt
OBJECTIVE: Lung cancer represents the leading cause of cancer death. EGFR mutations, detected in 10-40% of lung adenocarcinomas, are an essential key to therapeutic management. EGFR-activated mutations comprise mainly deletions in exon 19 and point mutations in exon 21. Although histology is the traditional method of detection, we investigated the role of cytology in EGFR mutations. STUDY DESIGN: A total of 774...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
